Advances in alcoholic liver disease

Bailliere's Best Practice and Research in Clinical Gastroenterology

Volumn 17, Issue 4, 2003, Pages 625-647

  Arteel, Gavin ^a   Marsano, Luis ^a   Mendez, Christian ^a   Bentley, Frederick ^a   McClain, Craig J ^a  

^a UNIVERSITY OF LOUISVILLE HOSPITAL   (United States)

Author keywords

Aetiology; Alcoholic liver disease; Diagnosis; Treatment

Indexed keywords

ACETALDEHYDE; ALANINE AMINOTRANSFERASE; ALCOHOL; ALDEHYDE DEHYDROGENASE; ALPHA TOCOPHEROL; ANTIINFLAMMATORY AGENT; ASPARTATE AMINOTRANSFERASE; AUTACOID; COLCHICINE; CORTICOSTEROID; CYTOCHROME P450 2E1; GAMMA GLUTAMYLTRANSFERASE; INTERLEUKIN 10; OXANDROLONE; PENTOXIFYLLINE; PROPYLTHIOURACIL; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; S ADENOSYLMETHIONINE; SILYBUM MARIANUM EXTRACT; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; NITROGEN; SILYMARIN;

ALCOHOL LIVER DISEASE; ALCOHOL WITHDRAWAL; ALTERNATIVE MEDICINE; DIET THERAPY; DRINKING BEHAVIOR; GENETIC POLYMORPHISM; HEPATITIS; HEREDITY; HOSPITAL PATIENT; HUMAN; LABORATORY TEST; LIFESTYLE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MORBIDITY; MORTALITY; OUTPATIENT CARE; PATHOGENESIS; PATIENT SELECTION; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; SMOKING CESSATION; WEIGHT REDUCTION; ABSTINENCE; ALCOHOL CONSUMPTION; ALCOHOL LIVER CIRRHOSIS; ALCOHOL METABOLISM; CHEMICAL ANALYSIS; CLINICAL TRIAL; HISTOLOGY; INFLAMMATORY CELL; LABORATORY DIAGNOSIS; LIVER INJURY; NUTRITION; OUTPATIENT; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PHYSICAL EXAMINATION; RISK FACTOR; SILYBUM MARIANUM;

EID: 0347983822     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1521-6918(03)00053-2     Document Type: Article

References (161)

1. Orholm M. Sorensen T.I. Bentsen K. et al. Mortality of alcohol abusing men prospectively assessed in relation to history of abuse and degree of liver injury Liver 5 1985 253-260
2. Grant B.F. DeBakey S. Zobeck T.S. Surveillance Report No. 18: Liver Cirrhosis Mortality in the United States, 1973-1988 1991 National Institute on Alcohol Abuse and Alcoholism, Division of Biometry and Epidemiology Rockville, MD
3. Propst A. Propst T. Zangerl G. et al. Prognosis and life expectancy in chronic liver disease Digestive Diseases and Sciences 40 1995 1805-1815
4. Chedid A. Mendenhall C.L. Gartside P. et al. Prognostic factors in alcoholic liver disease. VA Cooperative Study Group American Journal of Gastroenterology 86 1991 210-216
5. Becker U. Deis A. Sorensen T.I. et al. Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study Hepatology 23 1996 1025-1029
6. Fuchs C.S. Stampfer M.J. Colditz G.A. et al. Alcohol consumption and mortality among women New England Journal of Medicine 332 1995 1245-1250
7. Thun M.J. Peto R. Lopez A.D. et al. Alcohol consumption and mortality among middle-aged and elderly U.S. adults New England Journal of Medicine 337 1997 1705-1714
8. Grant B.F. Dufour M.C. Harford T.C. Epidemiology of alcoholic liver disease Seminars in Liver Disease 8 1988 12-25
9. McCullough A.J. Alcoholic liver disease. In Maddrey W.C. (Ed.), Schiff's Diseases of the Liver 1999 941-971 Lippincott, Raven Philadelphia
10. Espinoza P. Ducot B. Pelletier G. et al. Interobserver agreement in the physical diagnosis of alcoholic liver disease Digestive Diseases and Sciences 32 1987 244-247
11. Rosman A.S. Utility and evaluation of biochemical markers of alcohol consumption Journal of Substance Abuse 4 1992 277-297
12. Conigrave K.M. Saunders J.B. Whitfield J.B. Diagnostic tests for alcohol consumption Alcohol and Alcoholism 30 1995 13-26
13. Buchsbaum D.G. Buchanan R.G. Welsh J. et al. Screening for drinking disorders in the elderly using the CAGE questionnaire Journal of the American Geriatrics Society 40 1992 662-665
14. Girela E. Villanueva E. Hernandez-Cueto C. Luna J.D. Comparison of the CAGE questionnaire versus some biochemical markers in the diagnosis of alcoholism Alcohol and Alcoholism 29 1994 337-343
15. Bruguera M. Bordas J.M. Rodes J. Asymptomatic liver disease in alcoholics Archives of Pathology and Laboratory Medicine 101 1977 644-647
16. Leevy C.B. Fatty liver: a study of 720 patients with biopsy proven fatty liver and a review of the literature Medicine 41 1962 249
17. Bird G.L. Williams R. Factors determining cirrhosis in alcoholic liver disease Molecular Aspects of Medicine 10 1988 97-105
18. Pares A. Caballeria J. Bruguera M. et al. Histological course of alcoholic hepatitis. Influence of abstinence, sex and extent of hepatic damage Journal of Hepatology 2 1986 33-42
19. Bell H. Tallaksen C.M. Try K. Haug E. Carbohydrate-deficient transferrin and other markers of high alcohol consumption: a study of 502 patients admitted consecutively to a medical department Alcohol, Clinical and Experimental Research 18 1994 1103-1108
20. Cohen J.A. Kaplan M.M. The SGOT/SGPT ratio-an indicator of alcoholic liver disease Digestive Diseases and Sciences 24 1979 835-838
21. Himmelstein D.U. Woolhandler S.J. Adler R.D. Elevated SGOT/SGPT ratio in alcoholic patients with acetaminophen hepatotoxicity American Journal of Gastroenterology 79 1984 718-720
22. Matloff D.S. Selinger M.J. Kaplan M.M. Hepatic transaminase activity in alcoholic liver disease Gastroenterology 78 1980 1389-1392
23. Galambos J. Alcoholic Hepatitis 1974 Intercontinental Medical Book Co New York
24. Skude G. Wadstein J. Amylase, hepatic enzymes and bilirubin in serum of chronic alcoholics Acta Medica Scandinavica 201 1977 53-58
25. Morse R.M. Hurt R.D. Screening for alcoholism Journal of the American Medical Association 242 1979 2688-2690
26. Yersin B. Nicolet J.F. Dercrey H. et al. Screening for excessive alcohol drinking. Comparative value of carbohydrate-deficient transferrin, gamma-glutamyltransferase, and mean corpuscular volume Archieves of Internal Medicine 155 1995 1907-1911
27. Nilssen O. Huseby N.E. Hoyer G. et al. New alcohol markers-how useful are they in population studies: the Svalbard Study 1988-89 Alcohol, Clinical and Experimental Research 16 1992 82-86
28. Litten R.Z. Allen J.P. Fertig J.B. Gamma-glutamyltranspeptidase and carbohydrate deficient transferrin: alternative measures of excessive alcohol consumption Alcohol, Clinical and Experimental Research 19 1995 1541-1546
29. Maddrey W.C. Boitnott J.K. Bedine M.S. et al Corticosteroid therapy of alcoholic hepatitis Gastroenterology 75 1978 193-199
30. Carithers R.L.Jr. Herlong H.F. Diehl A.M. et al. Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial Annals of Internal Medicine 110 1989 685-690
31. McClain C. Hill D. Schmidt J. Diehl A.M. Cytokines and alcoholic liver disease Seminars in Liver Disease 13 1993 170-182
32. Van Ness M.M. Diehl A.M. Is liver biopsy useful in the evaluation of patients with chronically elevated liver enzymes? Annals of Internal Medicine 111 1989 473-478
33. Talley N.J. Roth A. Woods J. Hench V. Diagnostic value of liver biopsy in alcoholic liver disease Journal of Clinical Gastroenterology 10 1988 647-650
34. Teli M.R. Day C.P. Burt A.D. et al. Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver Lancet 346 1995 987-990
35. Fromenty B. Grimbert S. Mansouri A. et al. Hepatic mitochondrial DNA deletion in alcoholics: association with microvesicular steatosis Gastroenterology 108 1995 193-200
36. MacSween R.N. Burt A.D. Histologic spectrum of alcoholic liver disease Seminars in Liver Disease 6 1986 221-232
37. Chedid A. Mendenhall C.L. Tosch T. et al. Significance of megamitochondria in alcoholic liver disease Gatroenterology 90 1986 1858-1864
38. Lieber C.S. Metabolic effects of acetaldehyde Biochemical Society Transactions 16 1988 241-247
39. Klassen L.W. Tuma D. Sorrell M.F. Immune mechanisms of alcohol-induced liver disease Hepatology 22 1995 355-357
40. Niemela O. Distribution of ethanol-induced protein in vivo: relationship to tissue injury Free Radical Biology and Medicine 31 2001 1533-1538
41. Thiele G.M. Worrall S. Tuma D.J. et al. The chemistry and biological effects of malondialdehyde-acetaldehyde adducts Alcohol, Clinical and Experimental Research 25 5th supplement ISBRA 2001 218S-224S
42. Bardag-Gorce F. Yuan Q.X. Li J. et al. The effect of ethanol-induced cytochrome p4502E1 on the inhibition of proteasome activity by alcohol Biochemical and Biophysical Research Communications 279 2000 23-29
43. Ekstrom G. Ingelman-Sundberg M. Rat liver microsomal NADPH-supported oxidase activity and lipid peroxidation dependent on ethanol-cytochrome P-450 (P-450IIE1) Biochemical Pharmacology 38 1989 1313-1319
44. Cederbaum A.I. Wu D. Mari M. Bai J. CYP2E1-dependent toxicity and oxidative stress in HepG2 cells Free Radical Biology and Medicine 31 2001 1539-1543
45. Kono H. Bradford B.U. Yin M. et al. CYP2E1 is not involved in early alcohol-induced liver injury American Journal of Physiology 277 1999 G1259-G1267
46. Maher J. The CYP2E1 knockout delivers another punch: first ASH, now NASH. Alcoholic steatohepatitis. Nonalcoholic steatohepatitis Hepatology 33 2001 311-312
47. Lieber C.S. ALCOHOL: its metabolism and interaction with nutrients Annual Review of Nutrition 20 2000 395-430
48. Day C.P. James O.F. Hepatic steatosis: innocent bystander or guilty party? Hepatology 27 1998 1463-1466
49. Di Luzio N.R. A mechanism of the acute ethanol-induced fatty liver and the modification of liver injury by antioxidants American Journal of Pharmacy and the Sciences Supporting Public Health 15 1966 50-63
50. Shaw S. Jayatilleke E. Ross W.A. et al. Ethanol-induced lipid peroxidation: potentiation by long-term alcohol feeding and attenuation by methionine Journal of Laboratory and Clinical Medicine 98 1981 417-424
51. Patek A.J. Jr. Alcohol, malnutrition, and alcoholic cirrhosis American Journal of Clinical Nutrition 32 1979 1304-1312
52. Bujanda L. The effects of alcohol consumption upon the gastrointestinal tract American Journal of Gastroenterology 95 2000 3374-3382
53. Kono H. Rusyn I. Bradford B.U. et al. Allopurinol prevents early alcohol-induced liver injury in rats Journal of Pharmacology and Experimental Therapeutics 293 2000 296-303
54. Kono H. Rusyn I. Uesugi T. et al. Diphenyleniodonium sulfate, an NADPH oxidase inhibitor, prevents early alcohol-induced liver injury in the rat American Journal of Physiology: Gastrointestinal and Liver Physiology 280 2001 G1005-G1012
55. Kono H. Arteel G.E. Rusyn I. et al. Ebselen prevents early alcohol-induced liver injury in rats Free Radical Biology and Medicine 30 2001 403-411
56. McCord J.M. Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein) Journal of Biological Chemistry 244 1969 6049-6055
57. Polavarapu R. Spitz D.R. Sim J.E. et al. Increased lipid peroxidation and impaired antioxidant enzyme function is associated with pathological liver injury in experimental alcoholic liver disease in rats fed diets high in corn oil and fish oil Hepatology 27 1998 1317-1323
58. Wheeler M.D. Kono H. Yin M. et al. Delivery of the Cu/Zn-superoxide dismutase gene with adenovirus reduces early alcohol-induced liver injury in rats Gastroenterology 120 2001 1241-1250
59. Wheeler M.D. Nakagami M. Bradford B.U. et al. Overexpression of manganese superoxide dismutase prevents alcohol-induced liver injury in the rat Journal of Biological Chemistry 276 2001 36664-36672
60. Fridovich I. Superoxide radical and superoxide dismutases Annual Review of Biochemistry 64 1995 97-112
61. Klebanoff S.J. Myeloperoxidase-halide-hydrogen peroxide antibacterial system Journal of Bacteriology 95 1968 2131-2138
62. Beckman J.S. Beckman T.W. Chen J. et al. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide Proceedings of the National Academy of Sciences of the USA 87 1990 1620-1624
63. Beckman J.S. The physiological and pathophysiological chemistry of nitric oxide. In Lancaster J. (Ed.), Nitric Oxide: Principles and Actions 1996 1-82 Academic Press San Diego, CA
64. Hon W.M. Lee K.H. Khoo H.E. Nitric oxide in liver diseases: friend, foe, or just passerby? Annals of the New York Academy of Science 962 2002 275-295
65. Oshita M. Takei Y. Kawano S. et al. Endogenous nitric oxide attenuates ethanol-induced perturbation of hepatic circulation in the isolated perfused rat liver Hepatology 20 1994 961-965
66. Wiest R. Groszmann R.J. The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough Hepatology 35 2002 478-491
67. Kim Y.M. Kim T.H. Chung H.T. et al. Nitric oxide prevents tumor necrosis factor alpha-induced rat hepatocyte apoptosis by the interruption of mitochondrial apoptotic signaling through S-nitrosylation of caspase-8 Hepatology 32 2000 770-778
68. Rai R.M. Lee F.Y. Rosen A. et al. Impaired liver regeneration in inducible nitric oxide synthase deficient mice Proceedings of the National Academy of Sciences of the USA 95 1998 13829-13834
69. Tsukamoto H. Horne W. Kamimura S. et al. Experimental liver cirrhosis induced by alcohol and iron Journal of Clinical Investigation 96 1995 620-630
70. Donohue T.M. Jr. The ubiquitin-proteasome system and its role in ethanol-induced disorders Addiction Biology 7 2002 15-28
71. Allen R.G. Tresini M. Oxidative stress and gene regulation Free Radical Biology and Medicine 28 2000 463-499
72. Droge W. Free radicals in the physiological control of cell function Physiological Reviews 82 2002 47-95
73. Forman H.J. Torres M. Redox signaling in macrophages Molecular Aspects of Medicine 22 2001 189-216
74. Kamata H. Hirata H. Redox regulation of cellular signalling Cellular Signalling 11 1999 1-14
75. Ermak G. Davies K.J. Calcium and oxidative stress: from cell signaling to cell death Molecular Immunology 38 2002 713-721
76. Suzuki Y.J. Forman H.J. Sevanian A. Oxidants as stimulators of signal transduction Free Radical Biology and Medicine 22 1997 269-285
77. D'Angio C.T. Finkelstein J.N. Oxygen regulation of gene expression: a study in opposites Molecular Genetics and Metabolism 71 2000 371-380
78. Hoek J.B. Pastorino J.G. Ethanol, oxidative stress, and cytokine-induced liver cell injury Alcohol 27 2002 63-68
79. Spencer S. Rubin K. Lieber C.S. Depressed hepatic glutathione and increased diene conjugates in alcoholic liver disease: evidence of lipid peroxidation Digestive Diseases and Sciences 28 1983 585-589
80. Bigatello L.M. Broitman S.A. Fattori L. et al. Endotoxemia, encephalopathy, and mortality in cirrhotic patients American Journal of Gastroenterology 82 1987 11-15
81. Deaciuc I.V. Fortunato F. D'Souza N.B. et al. Modulation of caspase-3 activity and Fas ligand mRNA expression in rat liver cells in vivo by alcohol and lipopolysaccharide Alcohol, Clinical and Experimental Research 23 1999 349-356
82. MaClain C.J. Cohen D.A. Increased tumor necrosis factor production by monocytes in alcoholic hepatitis Hepatology 9 1989 349-351
83. Hill D.B. Marsano L. Cohen D. et al. Increased plasma interleukin-6 concentrations in alcoholic hepatitis Journal of Laboratory and Clinical Medicine 119 1992 547-552
84. Hill D.B. Marsano L.S. McClain C.J. Increased plasma interleukin-8 concentrations in alcoholic hepatitis Hepatology 18 1993 576-580
85. Devalaraja M.N. McClain C.J. Barve S. et al. Increased monocyte MCP-1 production in acute alcoholic hepatitis Cytokine 11 1999 875-881
86. Fisher N.C. Neil D.A. Williams A. Adams D.H. Serum concentrations and peripheral secretion of the beta chemokines monocyte chemoattractant protein 1 and macrophage inflammatory protein 1 alpha in alcoholic liver disease Gut 45 1999 416-420
87. McClain C.J. Hill D.B. Song Z. et al. Monocyte activation in alcoholic liver disease Alcohol 27 2002 53-61
88. Colell A. Garcia-Ruiz C. Miranda M. et al. Selective glutathione depletion of mitochondria by ethanol sensitizes hepatocytes to tumor necrosis factor Gastroenterology 115 1998 1541-1551
89. Pastorino J.G. Hoek J.B. Ethanol potentiates tumor necrosis factor-alpha cytotoxicity in hepatoma cells and primary rat hepatocytes by promoting induction of the mitochondrial permeability transition Hepatology 31 2000 1141-1152
90. Liu H. Jones B.E. Bradham C. Czaja M.J. Increased cytochrome P-450 2E1 expression sensitizes hepatocytes to c-Jun-mediated cell death from TNF-alpha American Journal of Physiology: Gastrointestinal and Liver Physiology 282 2002 G257-G266
91. Kim K.Y. Rhim T. Choi I. Kim S.S. N-acetylcysteine induces cell cycle arrest in hepatic stellate cells through its reducing activity Journal of Biological Chemistry 276 2001 40591-40598
92. Reeves H.L. Dack C.L. Peak M. et al. Stress-activated protein kinases in the activation of rat hepatic stellate cells in culture Journal of Hepatology 32 2000 465-472
93. Uesugi T. Froh M. Arteel G.E. et al. Role of lipopolysaccharide-binding protein in early alcohol-induced liver injury in mice Journal of Immunology 168 2002 2963-2969
94. Bradham C.A. Qian T. Streetz K. et al. The mitochondrial permeability transition is required for tumor necrosis factor alpha-mediated apoptosis and cytochrome c release Molecular and Cellular Biology 18 1998 6353-6364
95. Hatano E. Bradham C.A. Stark A. et al. The mitochondrial permeability transition augments Fas-induced apoptosis in mouse hepatocytes Journal of Biological Chemistry 275 2000 11814-11823
96. Uesugi T. Froh M. Arteel G.E. et al. Delivery of IkappaB superrepressor gene with adenovirus reduces early alcohol-induced liver injury in rats Hepatology 34 2001 1149-1157
97. McKim S.E. Konno A. Gabele E. et al. Cocoa extract protects against early alcohol-induced liver injury in the rat Archives of Biochemistry and Biophysics 406 2002 40-46
98. Pessayre D. Mansouri A. Fromenty B. Nonalcoholic steatosis and steatohepatitis. V. Mitochondrial dysfunction in steatohepatitis American Journal of Physiology: Gastrointestinal and Liver Physiology 282 2002 G193-G199
99. Hardardottir I. Doerrler W. Feingold K.R. Grunfeld C. Cytokines stimulate lipolysis and decrease lipoprotein lipase activity in cultured fat cells by a prostaglandin independent mechanism Biochemical and Biophysical Research Communications 186 1992 237-243
100. Feingold K.R. Grunfeld C. Tumor necrosis factor-alpha stimulates hepatic lipogenesis in the rat in vivo Journal of Clinical Investigation 80 1987 184-190
101. Nachiappan V. Curtiss D. Corkey B.E. Kilpatrick L. Cytokines inhibit fatty acid oxidation in isolated rat hepatocytes: synergy among TNF, IL-6, and IL-1 Shock 1 1994 123-129
102. Navasa M. Gordon D.A. Hariharan N. et al. Regulation of microsomal triglyceride transfer protein mRNA expression by endotoxin and cytokines Journal of Lipid Research 39 1998 1220-1230
103. Yin M. Wheeler M.D. Kono H. et al. Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice Gastroenterology 117 1999 942-952
104. Lelbach W.K. Liver damage in chronic alcoholism. Results of a clinical, clinical-chemical and bioptic-histological study in 526 alcoholic patients during a low-calorie diet in an open drinking sanatorium Acta Hepato-splenologica 13 1966 321-349
105. Day C.P. Who gets alcoholic liver disease: nature or nurture? Journal of the Royal College of Physicians, London 34 2000 557-562
106. Agarwal D.P. Genetic polymorphisms of alcohol metabolizing enzymes Pathologie-Biologie (Paris) 49 2001 703-709
107. Eriksson C.J. The role of acetaldehyde in the actions of alcohol (update 2000) Alcohol, Clinical and Experimental Research 25 5 supplement ISBRA 2001 15S-32S
108. Adams P.C. Agnew S. Alcoholism in hereditary hemochromatosis revisited: prevalence and clinical consequences among homozygous siblings Hepatology 23 1996 724-727
109. Grove J. Daly A.K. Bassendine M.F. Day C.P. Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis Hepatology 26 1997 143-146
110. Grove J. Daly A.K. Bassendine M.F. et al. Interleukin 10 promoter region polymorphisms and susceptibility to advanced liver disease Gut 46 2000 540-545
111. Powell Jr. W.J. Klatskin G. Duration of survival in patients with Laennec's cirrhosis. Influence of alcohol withdrawal, and possible effects of recent changes in general management of the disease American Journal of Medicine 44 1968 406-420
112. Merkel C. Marchesini G. Fabbri A. et al. The course of galactose elimination capacity in patients with alcoholic cirrhosis: possible use as a surrogate marker for death Hepatology 24 1996 820-823
113. Klatsky A.L. Armstrong M.A. Alcohol, smoking, coffee and cirrhosis American Journal of Epidemiology 136 1992 1248-1257
114. Corrao G. Lepore A.R. Torchio 5P. et al. The effect of drinking coffee and smoking cigarettes on the risk of cirrhosis associated with alcohol consumption. A case-control study. Provincial Group for the Study of Chronic Liver Disease European Journal of Epidemiology 10 1994 657-664
115. Pessione F. Ramond M.J. Njapoum C. et al. Cigarette smoking and hepatic lesions in patients with chronic hepatitis C Hepatology 34 2001 121-125
116. Raynard B. Balian A. Fallik D. et al. Risk factors of fibrosis in alcohol-induced liver disease Hepatology 35 2002 635-638
117. Mendenhall C. Roselle G.A. Gartside P. Moritz T. Relationship of protein calorie malnutrition to alcoholic liver disease: a reexamination of data from two Veterans Administration Cooperative Studies Alcohol, Clinical and Experimental Research 19 1995 635-641
118. Mendenhall C.L. Anderson S. Weesner R.E. et al. Protein calorie malnutrition associated with alcoholic hepatitis. Veterans Administration Cooperative Study Group on Alcoholic Hepatitis American Journal of Medicine 76(2) 1984 211-222
119. Mendenhall C.L. Moritz T.E. Roselle G.A. Morgan T.R. Nemchausky B.A. Tamburro C.H. Schiff E.R. McClain C.J. Marsano L.S. Allen J.I. Samanta A. Weesner R.E. Henderson W. Gartside P. Chen T.S. French S.W. Chedid A. A study of oral nutritional support with oxandrolone in malnourished patients with alcoholic hepatitis: results of a Department of Veterans Affairs Cooperative study Hepatology 17(4) 1993 564-576
120. Patek A.J. Post J. Ralnoff O.D. Dietary treatment of cirrhosis of the liver Journal of the American Medical Association 139 1948 543-549
121. Hirsch S. Bunout D. de la Maza P. et al. Controlled trial on nutrition supplementation in outpatients with symptomatic alcoholic cirrhosis Journal of Parenteral and Enteral Nutrition 17 1993 119-124
122. Hirsch S. de la Maza M.P. Gattas V. et al. Nutritional support in alcoholic cirrhotic patients improves host defenses Journal of the American College of Nutrition 18 1999 434-441
123. Kearns P.J. Young H. Garcia G. et al. Accelerated improvement of alcoholic liver disease with enteral nutrition Gastroenterology 102 1992 200-205
124. Cabre E. Rodriguez-Iglesias P. Caballeria J. et al. Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: a multicenter randomized trial Hepatology 32 2000 36-42
125. Orrego H. Blake J.E. Blendis L.M. et al. Long-term treatment of alcoholic liver disease with propylthiouracil New England Journal of Medicine 317 1987 1421-1427
126. Rambaldi A. Gluud C. Propylthiouracil for alcoholic liver disease Cochrane Database of Systematic Reviews 2 2002 CD002800
127. Kershenobich D. Vargas F. Garcia-Tsao G. et al. Colchicine in the treatment of cirrhosis of the liver New England Journal of Medicine 318 1988 1709-1713
128. Morgan T. Nemchausky N. Schiff E.R. et al. Colchicine does not prolong life in patients with advanced alcoholic cirrhosis: results of a prospective, randomized, placebo-controlled, multicenter VA trial (Csp 352) Gastroenterology 122 supplement 2002 641 abstract
129. Cortez-Pinto H. Alexandrino P. Camilo M.E. et al. Lack of effect of colchicine in alcoholic cirrhosis: final results of a double blind randomized trial European Journal of Gastroenterology and Hepatology 14 2002 377-381
130. Fulton F. McCullough A.J. Treatment of alcoholic hepatitis Clinics in Liver Disease 4 1998 799-819
131. Mendenhall C.L. Anderson S. Garcia-Pont P. et al. Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone New England Journal of Medicine 311 1984 1464-1470
132. Mathurin P, Mendenhall CL, Carithers Jr. RL et al. Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH. Journal of Hepatology 2002; 36: 480-487.
133. Akriviadis E. Botla R. Briggs W. et al. Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial Gastroenterology 119 2000 1637-1648
134. Ferenci P. Dragosics B. Dittrich H. et al. Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver Journal of Hepatology 9 1989 105-113
135. Pares A. Planas R. Torres M. et al. Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial Journal of Hepatology 28 1998 615-621
136. Mato J.M. Alvarez L. Ortiz P. Pajares M.A. S-adenosylmethionine synthesis: molecular mechanisms and clinical implications Pharmacology and Therapeutics 73 1997 265-280
137. Sanchez-Gongora E. Ruiz F. Mingorance J. et al. Interaction of liver methionine adenosyltransferase with hydroxyl radical FASEB Journal 11 1997 1013-1019
138. Chawla R.K. Watson W.H. Eastin C.E. et al. S-adenosylmethionine deficiency and TNF-alpha in lipopolysaccharide-induced hepatic injury American Journal of Physiology 275 1998 G125-G129
139. McClain C.J. Hill D.B. Song Z. et al. S-adenosylmethionine, cytokines, and alcoholic liver disease Alcohol 27 2002 185-192
140. Mato J.M. Camara J. Fernandez de Paz J. et al. S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial Journal of Hepatology 30 1999 1081-1089
141. McClain C. Hill D. Kugelmas M. Marsano L. Nutrition and liver disease. In RM B. (Ed.), Present Knowledge in Nutrition 2001 483-496 International Life Sciences Institute Washington, DC
142. Evstigneeva R.P. Volkov I.M. Chudinova V.V. Vitamin E as a universal antioxidant and stabilizer of biological membranes Membrane and Cell Biology 12 1998 151-172
143. Hill D.B. Devalaraja R. Joshi-Barve S. et al. Antioxidants attenuate nuclear factor-kappa B activation and tumor necrosis factor-alpha production in alcoholic hepatitis patient monocytes and rat Kupffer cells, in vitro Clinical Biochemistry 32 1999 563-570
144. Lee K.S. Buck M. Houglum K. Chojkier M. Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-myb expression Journal of Clinical Investigation 96 1995 2461-2468
145. de la Maza M.P. Petermann M. Bunout D. Hirsch S. Effects of long-term vitamin E supplementation in alcoholic cirrhotics Journal of the American College of Nutrition 14 1995 192-196
146. Meister A. Glutathione metabolism and its selective modification Journal of Biological Chemistry 263 1988 17205-17208
147. Pena L.R. Hill D.B. McClain C.J. Treatment with glutathione precursor decreases cytokine activity Journal of Parental and Enteral Nutrition 23 1999 1-6
148. Iimuro Y. Bradford B.U. Yamashina S. et al. The glutathione precursor L-2-oxothiazolidine-4-carboxylic acid protects against liver injury due to chronic enteral ethanol exposure in the rat Hepatology 31 2000 391-398
149. Cao Q. Mak K.M. Lieber C.S. Dilinoleoylphosphatidylcholine decreases LPS-induced TNF-alpha generation in Kupffer cells of ethanol-fed rats: respective roles of MAPKs and NF-kappaB Biochemical and Research Communications 29 2002 849-853
150. Veldt B.J. Laine F. Guillygomarc'h A. et al. Indication of liver transplantation in severe alcoholic liver cirrhosis: quantitative evaluation and optimal timing Journal of Hepatology 36 2002 93-98
151. Bravata D.M. Olkin I. Barnato A.E. et al. Employment and alcohol use after liver transplantation for alcoholic and nonalcoholic liver disease: a systematic review Liver Transplantation 7 2001 191-203
152. Neuberger J. Schulz K.H. Day C. et al. Transplantation for alcoholic liver disease Journal of Hepatology 36 2002 130-137
153. Bellamy C.O. DiMartini A.M. Ruppert K. et al. Liver transplantation for alcoholic cirrhosis: long term follow-up and impact of disease recurrence Transplantation 72 2001 619-626
154. Gish R.G. Lee A. Brooks L. et al. Long-term follow-up of patients diagnosed with alcohol dependence or alcohol abuse who were evaluated for liver transplantation Liver Transplantation 7 2001 581-587
155. Garcia-Tsao G. Current management of the complications of cirrhosis and portal hypertension: variceal hemorrhage, ascites, and spontaneous bacterial peritonitis Gastroenterology 120 2001 726-748
156. Burroughs A.K. Vangeli M. Transjugular intrahepatic portosystemic shunt versus endoscopic therapy: randomized trials for secondary prophylaxis of variceal bleeding: an updated meta-analysis Scandinavian Journal of Gastroenterology 37 2002 249-252
157. Arroyo V. Gines P. Gerbes A.L. et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club Hepatology 23 1996 164-176
158. Angeli P. Volpin R. Gerunda G. et al. Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide Hepatology 29 1999 1690-1697
159. Mitzner S.R. Stange J. Klammt S. et al. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial Liver Transplantation 6 2000 277-286
160. Blei A.T. Cordoba J. Hepatic encephalopathy American Journal of Gastroenterology 96 2001 1968-1976
161. Burroughs A.K. Patch D. Transjugular intrahepatic portosystemic shunt Seminars in Liver Disease 19 1999 457-473